Dr. Ketan K. Badani

At Mount Sinai Health System, Dr. Ketan K. Badani orchestrates a comprehensive urologic oncology program that unites surgical, medical and radiation oncology specialists alongside molecular pathologists, imaging experts and supportive care professionals in an integrated care model. Holding appointments as Professor of Urology at the Icahn School of Medicine, Vice Chairman of Urology and Robotic Operations, Director of the Comprehensive Kidney Cancer Center and Chief of Surgical Innovation and Strategy, he guides multidisciplinary teams in establishing evidence-based pathways for the management of kidney, prostate and bladder malignancies. His weekly interdisciplinary conferences review advanced imaging studies, genomic profiling reports, functional assessments and patient preferences to tailor treatment plans that balance oncologic control with quality-of-life considerations. Under his leadership, patient navigators coordinate diagnostic evaluations, preoperative counseling and psychosocial support services to reduce barriers to timely care. In collaboration with molecular pathologists, he incorporates biomarker assessments, such as PD-L1 expression and tumor mutational burden, into surgical decision making and systemic therapy selection. He chairs institutional committees responsible for surgical safety protocols, technology assessment and postoperative recovery pathways, fostering continuous quality improvement. Partnerships with rehabilitation therapists and pain management specialists ensure holistic postoperative care, addressing functional outcomes and symptom management. As a leader in the Society for Urologic Robotics and minimally invasive surgery forums, he represents Mount Sinai in national guideline development and shares best practices with peer institutions. He also oversees telehealth initiatives to facilitate virtual consultations and postoperative monitoring for patients who live at a distance. By embedding coordinated workflows, transparent communication and quality metrics dashboards throughout the care journey, he empowers patients with clear expectations and confidence in each treatment step. This patient-centered structure streamlines each stage of care, fostering trust and confidence in treatment decisions.

 

In his translational research program, Dr. Ketan K. Badani directs investigations that bridge surgical innovation and patient-centered outcomes to refine treatment strategies in urologic oncology. His laboratory and clinical teams apply advanced imaging analytics, three-dimensional surgical simulation and high-fidelity robotic training platforms to optimize techniques such as robotic partial nephrectomy and reconstructive urologic procedures that preserve organ function and urinary control. As Editor-in-Chief of Frontiers in Urologic Oncology, he oversees peer review of manuscripts exploring biomarkers predictive of surgical success, functional recovery metrics and health-related quality-of-life outcomes. His clinical studies include feasibility and safety evaluations of novel minimally invasive approaches, correlating perioperative variables with patient-reported outcomes to guide evidence-based refinements. Collaborating with biostatisticians and health services researchers, he integrates quality-of-life research into trial protocols to ensure that surgical innovations align with patient priorities for recovery and long-term well-being. He also co-chairs translational research forums that convene surgeons, basic scientists and industry partners to discuss practice-changing discoveries and emerging technologies. Under his mentorship, research fellows gain expertise in study design, protocol development and regulatory compliance, fostering the next generation of clinician scientists. Partnerships with medical technology companies enable early-phase assessments of robotic instruments and implantable devices, while cooperative group collaborations support multicenter trials validating functional outcomes across diverse patient populations. He presents key findings at international congresses and contributes to national guideline committees, translating robust scientific evidence into clinical practice recommendations. Through these translational efforts, Dr. Badani accelerates the adoption of innovative surgical strategies and enhances the precision of urologic oncology care. Patients benefit from treatment plans grounded in rigorous research and tailored to maximize both oncologic control and quality-of-life outcomes, fostering confidence in their surgical journey. 

 

Motivated by a dedication to education and community engagement, Dr. Ketan K. Badani transforms complex surgical advances into accessible learning experiences for patients, caregivers and healthcare professionals. As Professor of Urology and Vice Chairman at the Icahn School of Medicine, he crafts interdisciplinary curricula that combine simulation-based training, hands-on workshops and case-based seminars to elevate proficiency in robotic urologic surgery and reconstructive techniques. He has led live surgical demonstrations and presented refined methods, such as his first assistant sparing technique for partial nephrectomy, at major international forums, sharing practical insights that improve operative efficiency and patient recovery. Partnering with patient advocacy organizations, he develops multimedia guides and plain language materials that clarify treatment pathways, surgical options and postoperative care, making complex concepts understandable. He mentors medical students, residents and fellows through structured programs that emphasize clinical reasoning, professional ethics and research literacy. To extend reach, he directs telemedicine outreach clinics and webinars for rural and underserved communities, enabling access to expertise without travel burdens. As Editor-in-Chief of Frontiers in Urologic Oncology, he oversees publication of practitioner guides and patient education supplements, ensuring that current best practices are widely disseminated. He also contributes to online platforms that facilitate clinical trial matching, symptom monitoring and follow-up coordination. He collaborates with interdisciplinary teams to develop patient support networks and follow-up care models that address long-term recovery and wellness. By fostering a culture of transparent communication and continuous learning, he empowers patients to participate actively in decision making and strengthens collaboration among clinicians. Patients benefit from clear explanations and tailored resources that demystify complex procedures, fostering confidence and reducing uncertainty throughout their care.